235 related articles for article (PubMed ID: 37415443)
1. Adjunctive antibiotic therapy with clindamycin or linezolid in patients with group A streptococcus (GAS) meningitis.
Rezahosseini O; Roed C; Gitz Holler J; Frimodt-Møller N; Harboe ZB
Infect Dis (Lond); 2023 Oct; 55(10):751-753. PubMed ID: 37415443
[No Abstract] [Full Text] [Related]
2. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
Cortés-Penfield N; Ryder JH
Clin Infect Dis; 2023 Jan; 76(2):346-350. PubMed ID: 36056891
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.
Babiker A; Li X; Lai YL; Strich JR; Warner S; Sarzynski S; Dekker JP; Danner RL; Kadri SS
Lancet Infect Dis; 2021 May; 21(5):697-710. PubMed ID: 33333013
[TBL] [Abstract][Full Text] [Related]
4. Rare presentation of necrotising fasciitis and streptococcal toxic shock syndrome by group A streptococcus.
Saeed S; Alothman S; Ahmed L; Donaldson B
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28954758
[No Abstract] [Full Text] [Related]
5. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report.
Yokota K; Kawakami K
J Infect Chemother; 2024 Aug; 30(8):785-788. PubMed ID: 38185364
[TBL] [Abstract][Full Text] [Related]
7. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection.
Vilhonen J; Vuopio J; Vahlberg T; Gröndahl-Yli-Hannuksela K; Rantakokko-Jalava K; Oksi J
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1339-1348. PubMed ID: 32096108
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive Therapy With Clindamycin in Streptococcal Infection.
Sprute R; Salzberger B; Götz J; Jung N; Stocker L; Fätkenheuer G
Clin Infect Dis; 2023 Jun; 76(11):2043-2044. PubMed ID: 36815297
[No Abstract] [Full Text] [Related]
9. [Does the antitoxin activity of clindamycin decrease mortality in invasive streptococcal infections?].
Ferry T
Med Mal Infect; 2015 May; 45(5):185-6. PubMed ID: 26153577
[No Abstract] [Full Text] [Related]
10. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance.
Cornaglia G; Ligozzi M; Mazzariol A; Valentini M; Orefici G; Fontana R
Emerg Infect Dis; 1996; 2(4):339-42. PubMed ID: 9011381
[TBL] [Abstract][Full Text] [Related]
11. Editorial commentary: step on the GAS: are we almost there for clindamycin and intravenous immunoglobulin?
Tan LK; Sriskandan S
Clin Infect Dis; 2014 Aug; 59(3):366-8. PubMed ID: 24785238
[No Abstract] [Full Text] [Related]
12. Comment on Fox et al's presentation of two invasive group A streptococcal (GAS) infections.
Mulla ZD
J Emerg Med; 2003 May; 24(4):473-4. PubMed ID: 12745058
[No Abstract] [Full Text] [Related]
13. Revisiting the inoculum effect for Streptococcus pyogenes with a hollow fibre infection model.
Marum D; Manning L; Raby E
Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2137-2144. PubMed ID: 33948751
[TBL] [Abstract][Full Text] [Related]
14. Streptococcal myositis.
Mulla ZD
Br J Plast Surg; 2003 Jun; 56(4):424. PubMed ID: 12873476
[No Abstract] [Full Text] [Related]
15. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.
Zimbelman J; Palmer A; Todd J
Pediatr Infect Dis J; 1999 Dec; 18(12):1096-100. PubMed ID: 10608632
[TBL] [Abstract][Full Text] [Related]
16. Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release.
Coyle EA; Cha R; Rybak MJ
Antimicrob Agents Chemother; 2003 May; 47(5):1752-5. PubMed ID: 12709354
[TBL] [Abstract][Full Text] [Related]
17. Clindamycin in recurrent group A streptococcal pharyngotonsillitis. An alternative to tonsillectomy?
Stjernquist-Desatnik A; Orrling A; Schalén C; Kamme C
Adv Exp Med Biol; 1997; 418():435-7. PubMed ID: 9331687
[No Abstract] [Full Text] [Related]
18. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
[TBL] [Abstract][Full Text] [Related]
19. [Streptococcus pyogenes an emerging pathogen].
Cohen R; Aujard Y; Bidet P; Bourrillon A; Bingen E; Foucaud P; François M; Garnier JM; Gendrel D; Guillot M; Hau I; Olivier C; Quinet B; Raymond J
Arch Pediatr; 2005 Jul; 12(7):1065-7. PubMed ID: 15913971
[No Abstract] [Full Text] [Related]
20. Current therapy of group A streptococcal pharyngitis.
Dajani AS
Pediatr Ann; 1998 May; 27(5):277-80. PubMed ID: 9622810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
